The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infections

The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infections

IntroductionImmunocompromised patients with moderate to severe viral respiratory tract infections (VRTIs) may benefit from intravenous immune globulin (IVIG) in combination with antivirals. The impact of this therapy on hospital resource utilization is unknown. The purpose of this study was to asses...

Full description

Saved in:

Bibliographic Details
Main Authors:	Antoine Azar, M. Chris Runken, Eric Moughames, Reuben Howden, Joshua Oh, Christopher M. Blanchette
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	viral respiratory tract infection immune deficiency intravenous immune globulin healthcare resource utilization immunocompromised patients
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1513712/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum lipid metabolites predict the efficacy of intravenous immune globulin therapy in patients with pediatric dilated cardiomyopathy
by: Zhiyuan Wang, et al.
Published: (2025-05-01)

Secondary immune thrombocytopenic purpura: An unusual complication of scrub typhus
by: Jency Auxilia, et al.
Published: (2025-01-01)

The intricate interplay among microbiota, mucosal immunity, and viral infection in the respiratory tract
by: Xinyue Li, et al.
Published: (2025-04-01)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01)

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

Respiratory microbiota, host immunity, respiratory viral infections and malignant tumors
by: Xinjie Jiang, et al.
Published: (2025-07-01)

Clinical Characteristics of Cytomegalovirus Disease of the Upper Gastrointestinal Tract: A 10-Year Multicenter Retrospective Study
by: Ga-Ram You, et al.
Published: (2023-12-01)

Viral-based gene therapy clinical trials for immune deficiencies and blood disorders from 2013 until 2023 - an overview
by: Shirin Eshghi, et al.
Published: (2025-03-01)

Editorial: Innate and adaptive immune responses to viral infection
by: Stefania Varchetta, et al.
Published: (2025-01-01)

Effect of intravenous iron supply in patients with heart failure with reduced ejection fraction – a literature review
by: Katarzyna Dąbek, et al.
Published: (2024-12-01)

Cycloferon Efficacy in the Treatment of Acute Respiratory Tract Viral Infection and Influenza During the Morbidity Outbreak in 2009-2010
by: M. G. Pomantsov, et al.
Published: (2020-05-01)

Analysis of rare events in healthcare intervention using department of defense data: intravenous immune globulin therapy for bullous pemphigoid
by: Onur Baser, et al.
Published: (2025-04-01)

Peculiar features of intravenous immunoglobulins application in rheumatic diseases
by: O. N. Egorova, et al.
Published: (2024-06-01)

Accounting for the geometry of the respiratory tract in viral infections
by: Thomas Williams, et al.
Published: (2025-06-01)

Improvement of Natural Resistance in Children for Prophylaxis of Influenza and Acute Respiratory Tract Viral Infections (Results of Multicentre Randomized Trials)
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Torque Teno Virus: Lights and Shades
by: Paola Brani, et al.
Published: (2025-02-01)

Immunity and the infant GI-tract
by: L. Rees
Published: (2005-07-01)

Advances in the study of disulfidptosis in digestive tract tumors
by: Yue Chen, et al.
Published: (2025-02-01)

The relationship between selenium and viral diseases
by: Jiali Li, et al.
Published: (2025-03-01)

Intravenous iron for iron deficiency in heart failure with preserved ejection fraction. A multivariate analysis
by: Noverraz Viviane, et al.
Published: (2025-08-01)

Evaluation of eosinophil, immune-globulin E and Interleukin 6 levels in bronchial asthmatic children after management with needle and laser acupuncture
by: Inas E M. Ahmed Kamel, et al.
Published: (2024-01-01)

Efficacy of intravenous immunoglobulin in recurrent pregnancy loss: a retrospective analysis of patients with abnormal cellular immunity
by: Jae Won Han, et al.
Published: (2025-06-01)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013-01-01)

Aeromonas hydrophila dose and post-immunostimulation period as immunomodulatory effect indicator on Nile tilapia (Oreochromis niloticus)
by: Erika do Carmo Ota, et al.
Published: (2024-12-01)

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01)

Does the Use of Intravenous Immunoglobulin Improve Clinical Outcomes in Adults With Autoimmune Encephalitis? A Systematic Review
by: Anahat Kalra, et al.
Published: (2025-05-01)

Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: E. S. Orlova, et al.
Published: (2025-01-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

Cycloferon, as an Agent in the Therapy and Urgent Prophylaxis of Influenza and Acute Respiratory Tract Viral Infection (Multicentre Randomized Controlled Comparative Study)
by: T. V. Sologub, et al.
Published: (2020-05-01)

Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01)

Intravenous iron therapy for heart failure and iron deficiency: An updated meta‐analysis of randomized clinical trials
by: Mushood Ahmed, et al.
Published: (2025-02-01)

Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia
by: Marković-Sovtić Gordana, et al.
Published: (2013-01-01)

Intravenous Immunoglobulin-Induced Dyspnea and Bradycardia in a Patient with Guillain–Barre Syndrome
by: Harleen Kaur, et al.
Published: (2024-10-01)

ESTIMATION OF THE PERCENTAGE OF LACTOFERRIN AND IMMUNE PROTEINS IgG IN BUFFALO COLOSTRUM WITHIN FIVE DAYS OF BIRTH
by: Saja Qasim, et al.
Published: (2024-12-01)

One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States
by: Christopher M. Blanchette, et al.
Published: (2017-07-01)

Chronic Viral Infections and Al Amyloidosis: An Uncommon Association
by: Alberto Palladini, et al.
Published: (2025-04-01)

Therapeutic efficacy of intravenous immunoglobulin in ulcerative colitis
by: LONG Qian, et al.
Published: (2025-04-01)

CLINICAL AND PATHOGENETIC SUBSTANTIATION AND EFFICACY OF INTRAVENOUS APPLICATION OF IMMUNOGLOBULIN IN CHILDREN WITH BACTERIAL PURULENT MENINGITIS
by: T. E. Makarova, et al.
Published: (2015-08-01)

The immune mechanisms of the urinary tract against infections
by: Yilin Hou, et al.
Published: (2025-04-01)